A Phase I Trial of Pox PSA vaccines (PROSTVAC®-VF) with B7-1, ICAM-1, and LFA-3 co-stimulatory molecules (TRICOMTM) in Patients with Prostate Cancer. The gene discussed is CD58; the disease is Familial prostate cancer.